文献速递临床微生物分子诊断

16S rRNA靶向测序与培养在无菌体液样本细菌鉴定中的比较:10年临床实验室回顾

Comparison of 16S Ribosomal RNA Targeted Sequencing and Culture for Bacterial Identification in Normally Sterile Body Fluid Samples: Report of a 10-Year Clinical Laboratory Review.
PubMed 文献 · Ann Lab Med · 2020-01-01

该研究回顾了10年间312例无菌体液样本,同时用16S rRNA靶向测序和培养鉴定细菌。两者结果一致率为92.0%(287/312)。在16例测序阳性而培养阴性的样本中,8例检出临床相关菌,且均来自抗生素预处理患者。测序联合培养的诊断阳性率为11.2%,单独培养为6.1%。

要点

  • 16S rRNA测序与培养在无菌体液样本中结果一致率高(92.0%)。
  • 测序可检出抗生素预处理后培养阴性的临床相关细菌。
  • 测序联合培养的诊断阳性率(11.2%)高于单独培养(6.1%)。

核心结论

  • 16S rRNA靶向测序联合培养有助于鉴定无菌体液样本中的细菌,尤其适用于抗生素预处理患者和怀疑厌氧菌感染时。

研究设计与样本

  • 10年临床实验室回顾性研究,共纳入312例无菌体液样本(脑脊液、心包液、腹腔液和胸膜液),同时进行16S rRNA靶向测序和培养。

主要发现

  • 287/312(92.0%)样本结果一致,包括277例(88.8%)阴性和10例(3.2%)阳性。
  • 16例测序阳性而培养阴性的样本中,8例检出临床相关菌,包括Fusobacterium nucleatum subsp. nucleatum、Streptococcus pneumoniae和Staphylococcus spp.。
  • 所有测序阳性培养阴性的样本均来自抗生素预处理患者。
  • 测序联合培养的诊断阳性率为11.2%,单独培养为6.1%。

关键数值与推荐

  • 结果一致率:287/312(92.0%)。
  • 阴性一致:277/312(88.8%);阳性一致:10/312(3.2%)。
  • 诊断阳性率:测序联合培养11.2%,单独培养6.1%。

临床怎么用

  • 对于抗生素预处理后的无菌体液样本,可考虑16S rRNA靶向测序辅助鉴定细菌。
  • 怀疑厌氧菌感染时,16S rRNA靶向测序联合培养可能提高检出率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As 16S ribosomal RNA (rRNA)-targeted sequencing can detect DNA from non-viable bacteria, it can be used to identify pathogens from clinical samples even in patients pretreated with antibiotics. We compared the results of 16S rRNA-targeted sequencing and culture for identifying bacterial species in normally sterile body fluid (NSBF): cerebrospinal, pericardial, peritoneal and pleural fluids. Over a 10-year period, a total of 312 NSBF samples were evaluated simultaneously using 16S rRNA-targeted sequencing and culture. Results were concordant in 287/312 (92.0%) samples, including 277 (88.8%) negative and 10 (3.2%) positive samples. Of the 16 sequencing-positive, culture-negative samples, eight showed clinically relevant isolates that included Fusobacterium nucleatum subsp. nucleatum, Streptococcus pneumoniae, and Staphylococcus spp. All these samples were obtained from the patients pretreated with antibiotics. The diagnostic yield of 16S rRNA-targeted sequencing combined with culture was 11.2%, while that of culture alone was 6.1%. 16S rRNA-targeted sequencing in conjunction with culture could be useful for identifying bacteria in NSBF samples, especially when patients have been pretreated with antibiotics and when anaerobic infection is suspected.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Yoo IY, Kang OK, Lee MK, et al. Comparison of 16S Ribosomal RNA Targeted Sequencing and Culture for Bacterial Identification in Normally Sterile Body Fluid Samples: Report of a 10-Year Clinical Laboratory Review. Ann Lab Med. 2020. PMID: 31432641. doi:10.3343/alm.2020.40.1.63

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。